Insider Transactions in Q2 2021 at Bio Techne Corp (TECH)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 18
2021
|
Charles R. Kummeth Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,909
-0.93%
|
$1,306,141
$449.73 P/Share
|
|
Jun 17
2021
|
Charles R. Kummeth Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,589
-1.46%
|
$4,315,050
$450.85 P/Share
|
|
Jun 14
2021
|
Charles R. Kummeth Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
7,481
-2.15%
|
$3,358,969
$449.6 P/Share
|
|
Jun 09
2021
|
Kim Kelderman Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
811
-100.0%
|
$351,163
$433.0 P/Share
|
|
Jun 07
2021
|
James Hippel CFO |
SELL
Open market or private sale
|
Direct |
9,942
-11.43%
|
$4,195,524
$422.27 P/Share
|
|
Jun 07
2021
|
James Hippel CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,942
+34.26%
|
$1,053,852
$106.59 P/Share
|
|
May 25
2021
|
Charles R. Kummeth Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
21,305
-10.89%
|
$8,948,100
$420.12 P/Share
|
|
May 25
2021
|
Charles R. Kummeth Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
36,849
+15.85%
|
$3,463,806
$94.35 P/Share
|
|
May 25
2021
|
Kim Kelderman Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
845
-51.03%
|
$358,280
$424.0 P/Share
|
|
May 01
2021
|
Kim Kelderman Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
856
-34.08%
|
$365,512
$427.49 P/Share
|
|
May 01
2021
|
Kim Kelderman Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,667
+39.89%
|
-
|